Since high HER2 and RUNX2 status are independent poor prognostic factors in breast cancer, both parameters together seems to be a novel and combined indicator for prognosis assessment and further studies on the cooperation of both these factors are justified. This evidence concerns the gene RUNX2 and breast carcinoma.